Di 12-ê Adara 2022-an de, NMPA (SFDA) agahdariyek pejirand ku guhertina serîlêdana ji bo ceribandina xweser a hilberên antîjenê COVID-19 ji hêla Nanjing Vazyme Biotech Co., Ltd, Beijing Jinwofu Bioengineering Technology Co., Ltd, Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, Guangzhou Wondfo B...
Zêdetir bixwînin